To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Has McGlashan poisoned the impact investment well?
Don’t be surprised if TPG goes on to successfully raise the second Rise Fund. But the actions of its erstwhile boss may make it harder for other impact investors, PEI senior editors Toby Mitchenall and Isobel Markham find.
